论文部分内容阅读
目的:评价检测冠心病患者血清肌钙蛋白Ⅰ(cTnI)及超敏C反应蛋白(hs-CRP)水平的临床意义。方法:对82例冠心病患者及40例健康体检者血清cTnI及hs-CRP水平进行检测。结果:冠心病组患者血清hs-CRP、cTnI水平均显著高于正常对照组,差异均有统计学意义(P<0.05);稳定型心绞痛(SAP)组、不稳定型心绞痛(UAP)组患者血清hs-CRP、cTnI水平均显著低于急性心肌梗死(AMI)组,而SAP组患者血清hs-CRP、cTnI水平显著低于UAP组,差异亦均有统计学意义(P<0.05)。结论:检测冠心病患者血清cTnI及hs-CRP水平对患者疾病预测及治疗具有重要的临床意义。
Objective: To evaluate the clinical significance of detecting serum cTnI and hs-CRP in patients with coronary heart disease. Methods: Serum levels of cTnI and hs-CRP were measured in 82 patients with coronary heart disease and 40 healthy subjects. Results: The serum levels of hs-CRP and cTnI in patients with coronary heart disease were significantly higher than those in the normal control group (P <0.05). Patients with stable angina pectoris (SAP) and patients with unstable angina pectoris (UAP) The levels of hs-CRP and cTnI in serum were significantly lower than those in AMI group, while the levels of hs-CRP and cTnI in SAP group were significantly lower than those in UAP group (P <0.05). Conclusion: Detecting serum levels of cTnI and hs-CRP in patients with coronary heart disease has important clinical significance for the prediction and treatment of patients’ disease.